Page last updated: 2024-08-21

indazoles and Cancer, Second Primary

indazoles has been researched along with Cancer, Second Primary in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Djebli, N; González-Sales, M; Jaminion, F; Meneses-Lorente, G; Mercier, F1
Acar, R; Akgul, F; Artac, M; Aydin, SG; Bahceci, A; Besiroglu, M; Bilici, A; Cinkir, HY; Dal, P; Demir, H; Demiray, AG; Derin, S; Eraslan, E; Erdem, D; Ergun, Y; Erol, C; Goksu, SS; Guc, ZG; Gumusay, O; Gunaydin, UM; Kaplan, MA; Karaagac, M; Karaca, M; Koca, S; Koral, L; Menekse, S; Ocak, B; Ozkul, O; Ozveren, A; Ozyukseler, DT; Paydas, S; Sahin, S; Sakalar, T; Sakin, A; Seker, MM; Sunar, V; Turhal, S; Unal, OU; Yekeduz, E1
Browne, LP; Cost, CR; Galambos, C; Knight-Perry, J; Koo, J1
Cook, G; Goh, V; Kelly-Morland, C; Mallett, S; Montana, G; Nathan, P; Rudman, S1
Adachi, A; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M1

Reviews

1 review(s) available for indazoles and Cancer, Second Primary

ArticleYear
Pediatric Metastatic Cardiac Angiosarcoma Successfully Treated With Multimodal Therapy: Case Report and Review of Literature.
    Journal of pediatric hematology/oncology, 2021, 03-01, Volume: 43, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Chemoradiotherapy; Child; Combined Modality Therapy; Heart Neoplasms; Hemangiosarcoma; Humans; Indazoles; Male; Neoplasms, Second Primary; Prognosis; Pyrimidines; Sulfonamides; Surgical Procedures, Operative

2021

Trials

1 trial(s) available for indazoles and Cancer, Second Primary

ArticleYear
Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated
    BMC cancer, 2017, 06-02, Volume: 17, Issue:1

    Topics: Adult; Aged; Axitinib; Bevacizumab; Carcinoma, Renal Cell; Cell Proliferation; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Imidazoles; Indazoles; Indoles; London; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasms, Second Primary; Positron-Emission Tomography; Pyrimidines; Pyrroles; Sulfonamides; Sunitinib; Treatment Outcome

2017

Other Studies

3 other study(ies) available for indazoles and Cancer, Second Primary

ArticleYear
Efficacy and safety exposure-response analyses of entrectinib in patients with advanced or metastatic solid tumors.
    Cancer chemotherapy and pharmacology, 2022, Volume: 89, Issue:3

    Topics: Adult; Benzamides; Carcinoma, Non-Small-Cell Lung; Child; Humans; Indazoles; Lung Neoplasms; Neoplasms, Second Primary; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases

2022
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
    Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:11

    Topics: Adult; Female; Humans; Indazoles; Leiomyosarcoma; Male; Middle Aged; Neoplasms, Second Primary; Retrospective Studies; Sarcoma; Sarcoma, Synovial; Soft Tissue Neoplasms; Turkey

2023
Long-term survival of a patient with neurofibromatosis type 1 diagnosed with multiple malignant peripheral nerve sheath tumors.
    The Journal of dermatology, 2019, Volume: 46, Issue:1

    Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Humans; Indazoles; Magnetic Resonance Imaging; Middle Aged; Neoplasms, Second Primary; Nerve Sheath Neoplasms; Neurofibromatosis 1; Pyrimidines; Radiotherapy, Adjuvant; Skin; Skin Neoplasms; Sulfonamides; Time Factors; Treatment Outcome

2019